Sign In  |  Register  |  About Mill Valley  |  Contact Us

Mill Valley, CA
September 01, 2020 1:29pm
7-Day Forecast | Traffic

  • Search Hotels in Mill Valley

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about INCY

Recent news which mentions INCY

< Previous 1 2 3 4 5 6 7 8 Next >
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
Tickers ABEO ACER AFIB AGTC
Tags LIXT NRBO DRRX
From Benzinga
The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
Tickers ADTX AFIB AGTC ARAV
Tags BNR GLPG TCRR
From Benzinga
Attention Biotech Investors: Mark Your Calendar For October PDUFA Dates
Tickers ANIP AVDL BHC CALT
Tags SGEN IBB VRCA
From Benzinga
More than a quarter of Nasdaq-100 stocks are in bear markets — Wall Street sees a buying opportunity
Tickers AAPL AMGN AMZN ATVI
Tags ILMN NTES ZM
From MarketWatch
Only 47 stocks in the S&P 500 have fallen over the past year — Wall Street predicts they will climb up to 54% in 12 months
Tickers AKAM AMGN APD ATO
Tags HRL VFC PCAR
From MarketWatch
The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive
Tickers AFIB ALT AMZN APYX
Tags Market News SBTX DVAX
From Benzinga
Syndax Pharma, Incyte Ink Licensing Pact For Graft Vs. Host Disease Candidate
Tickers INCY SNDX
Tags General Small Cap Benzinga
From Benzinga
Expert Ratings For Incyte
Tickers INCY
Tags Market News INCY Benzinga
From Benzinga
Incyte, Knight Therapeutics Ink Distribution Pact For Two Cancer Drugs In Latin America
Tickers INCY
Tags Biotech Diffuse Large B/Cell Lymphoma Benzinga
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 23, 2021
Tickers AMGN ANNX AOSL ARGX
Tags OVV OXLC BIIB
From Benzinga
BriaCell's Survival Story Could Mean a Better Chance of Survival for Women Suffering from Breast Cancer
Tickers BCTX INCY
Tags BriaCell Therapeutics General Movers & Shakers
From Benzinga
The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data
Tickers ABCL ABSI AFIB ALZN
Tags GRPH AFIB DXCM
From Benzinga
10 Biggest Price Target Changes For Thursday
Tickers FDX INCY KBH LEN
Tags INCY Homebuilding FDX
From Benzinga
Back To Back FDA Approval For Incyte - This Time For Jakafi In GVHD
Tickers INCY
Tags graft versus host disease News Health Care
From Benzinga
Facebook, Incyte Fall Despite the Nasdaq's Strong Wednesday Start
Tickers FB INCY
Tags ^IXIC FB Market News
From Motley Fool
The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs
Tickers ABEO ABSI AFIB AMAM
Tags Biotech LPTX LIXT
From Benzinga
Incyte's Topical JAK Inhibitor Scores FDA Approval For Atopic Dermatitis
Tickers INCY
Tags FDA General Briefs
From Benzinga
The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data
Tickers ABSI ADTX AERI AFIB
Tags Market News EIGR EDSA
From Benzinga
Incyte's Pemazyre Wins Conditional Approval For Bile Duct Cancer In Canada
Tickers INCY
Tags General FDA Market News
From Benzinga
Is AbbVie a Bad News Buy?
Tickers ABBV INCY LLY PFE
Tags PFE Market News INCY
From Motley Fool
The Week Ahead In Biotech (Sept. 19-25): Incyte, Verrica FDA Decisions And Conference Presentations In The Spotlight
Tickers AGTC APRE BMY BNTX
Tags JNJ INCY APRE
From Benzinga
Price Over Earnings Overview: Incyte
Tickers INCY
Tags BZI/PE Market News Markets
From Benzinga
FDA Hits JAK inhibitors With Heart Safety, Cancer Warnings: All You Need To Know
Tickers ABBV BMY INCY LLY
Tags PFE News Biotech
From Benzinga
Attention Biotech Investors: Mark Your Calendar For September PDUFA Dates
Tickers ABBV ASND BGNE BIIB
Tags Biotech IMPL MIRM
From Benzinga
If you’ve got the stock market jitters, here are 20 companies in two defensive sectors
Tickers ABC AES ANTM BAX
Tags BMY MRK BAX
From MarketWatch
The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration
Tickers AGEN ALKS ALZN BLFS
Tags Market News NVS ALKS
From Benzinga
Incyte - MorphoSys's Diffuse Large B-Cell Lymphoma Drug Wins European Approval
Tickers INCY MOR
Tags News INCY Health Care
From Benzinga
These 20 ‘left behind’ stocks among the S&P 500 are expected to rise up to 59% over 12 months
Tickers AAPL AMZN ATVI BAX
Tags VFC NEM TTWO
From MarketWatch
BriaCell, ImaginAb Join Forces To Assess Imaging Tech In Breast Cancer Trial
Tickers BCTX INCY
Tags Benzinga Biotech Movers
From Benzinga
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
Tickers ABSI ABVC ACAD ACHV
Tags TLSA FDA HRTX
From Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MillValley.com & California Media Partners, LLC. All rights reserved.